大博医疗
(002901)
| 流通市值：115.60亿 | | | 总市值：165.94亿 |
| 流通股本：2.88亿 | | | 总股本：4.14亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,339,884,360.68 | 641,496,893.47 | 2,600,859,747.67 | 1,876,254,824.66 |
| 营业收入 | 1,339,884,360.68 | 641,496,893.47 | 2,600,859,747.67 | 1,876,254,824.66 |
| 二、营业总成本 | 946,513,275.81 | 460,125,572.77 | 1,948,789,556.99 | 1,409,952,460.92 |
| 营业成本 | 342,335,517.92 | 165,746,915.26 | 767,186,046.77 | 539,806,274.28 |
| 税金及附加 | 19,737,548.59 | 9,888,765.37 | 36,479,100.35 | 26,554,607.37 |
| 销售费用 | 351,414,240.6 | 171,440,269.24 | 692,354,067 | 503,760,426.79 |
| 管理费用 | 68,550,261.54 | 33,358,556.56 | 152,398,199.63 | 113,460,049.02 |
| 研发费用 | 167,514,385.27 | 78,888,340.64 | 331,197,614.5 | 250,245,754.07 |
| 财务费用 | -3,038,678.11 | 802,725.7 | -30,825,471.26 | -23,874,650.61 |
| 其中:利息费用 | 2,308,772.15 | 1,306,232.03 | 6,176,130.6 | 4,904,153.66 |
| 其中:利息收入 | 12,654,306.12 | 7,193,347.21 | 27,486,848.7 | 20,314,304.32 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 65,233,329.47 | 10,594,554.75 | 49,413,965.8 | 37,714,385.71 |
| 加:投资收益 | 1,142,353.45 | 479,554.97 | 4,720,096.25 | 5,808,707.64 |
| 资产处置收益 | -186,561.93 | 6,459.83 | 622,992.64 | 77,132.18 |
| 资产减值损失(新) | -34,887,447.86 | -15,297,890.63 | -64,855,384.85 | -45,966,819.41 |
| 信用减值损失(新) | -2,669,177.08 | 1,039,682.21 | -2,149,393.05 | 2,974,442.76 |
| 其他收益 | 13,732,513.01 | 6,461,374.84 | 97,821,165.82 | 47,448,522.36 |
| 四、营业利润 | 435,736,093.93 | 184,655,056.67 | 737,643,633.29 | 514,358,734.98 |
| 加:营业外收入 | 461,234.01 | 114,133.7 | 1,131,435.55 | 659,769.65 |
| 减:营业外支出 | 463,600.22 | 434,516.49 | 8,730,838.92 | 674,157.41 |
| 五、利润总额 | 435,733,727.72 | 184,334,673.88 | 730,044,229.92 | 514,344,347.22 |
| 减:所得税费用 | 59,213,045.2 | 22,444,370 | 93,165,497.8 | 65,520,677.92 |
| 六、净利润 | 376,520,682.52 | 161,890,303.88 | 636,878,732.12 | 448,823,669.3 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 376,520,682.52 | 161,890,303.88 | 636,835,173.88 | 448,823,669.3 |
| 终止经营净利润 | - | - | 43,558.24 | - |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 353,331,905.24 | 146,565,626.19 | 599,631,709.82 | 424,646,236.99 |
| 少数股东损益 | 23,188,777.28 | 15,324,677.69 | 37,247,022.3 | 24,177,432.31 |
| 扣除非经常损益后的净利润 | 278,595,726.04 | 131,999,195.79 | 479,640,950.33 | 345,970,933.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.86 | 0.36 | 1.47 | 1.04 |
| (二)稀释每股收益 | 0.86 | 0.36 | 1.47 | 1.04 |
| 八、其他综合收益 | -625,725.49 | -708,649.52 | 57,287.36 | 385,712.63 |
| 归属于母公司股东的其他综合收益 | -323,335.59 | -523,403.58 | 151,481.72 | 285,174.35 |
| 九、综合收益总额 | 375,894,957.03 | 161,181,654.36 | 636,936,019.48 | 449,209,381.93 |
| 归属于母公司股东的综合收益总额 | 353,008,569.65 | 146,042,222.61 | 599,783,191.54 | 424,931,411.34 |
| 归属于少数股东的综合收益总额 | 22,886,387.38 | 15,139,431.75 | 37,152,827.94 | 24,277,970.59 |
| 公告日期 | 2026-08-27 | 2026-04-30 | 2026-04-24 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |